Darren K McGuire
Overview
Explore the profile of Darren K McGuire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
457
Citations
35025
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bhatt A, Bhatt D, Steg P, Szarek M, Cannon C, Leiter L, et al.
J Am Coll Cardiol
. 2024 Sep;
84(12):1078-1088.
PMID: 39260929
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve health status in heart failure (HF) across the left ejection fraction ejection spectrum. However, the effects of SGLT1 and SGLT2 inhibition on health...
12.
Sridhar V, Cosentino F, Dagogo-Jack S, McGuire D, Pratley R, Cater N, et al.
Diabetes Obes Metab
. 2024 Sep;
26(11):5336-5346.
PMID: 39219437
Aim: To conduct post hoc analyses of the VERTIS CV (NCT01986881) trial to explore the effects of ertugliflozin on serum uric acid (UA) and gout-related outcomes. Materials And Methods: Participants...
13.
Apperloo E, Neuen B, Fletcher R, Jongs N, Anker S, Bhatt D, et al.
Lancet Diabetes Endocrinol
. 2024 Jul;
12(8):545-557.
PMID: 38991584
Background: SGLT2 inhibitors and GLP-1 receptor agonists both improve cardiovascular and kidney outcomes in patients with type 2 diabetes. We sought to evaluate whether the benefits of SGLT2 inhibitors are...
14.
Tannu M, Kaltenbach L, Pagidipati N, McGuire D, Aroda V, Pop-Busui R, et al.
Circulation
. 2024 Jun;
150(3):180-189.
PMID: 38934111
Background: Results from the COORDINATE-Diabetes trial (Coordinating Cardiology Clinics Randomized Trial of Interventions to Improve Outcomes - Diabetes) demonstrated that a multifaceted, clinic-based intervention increased prescription of evidence-based medical therapies...
15.
Gami A, Blumenthal R, McGuire D, Sarkar S, Kohli P
J Am Heart Assoc
. 2024 Jun;
13(12):e034053.
PMID: 38879449
Following the publication of results from multiple landmark cardiovascular outcome trials of antihyperglycemic medications over the past 8 years, there has been a major shift in the focus of care...
16.
Odutayo A, Cosentino F, Pratley R, Dagogo-Jack S, McGuire D, Frederich R, et al.
Diabetes Obes Metab
. 2024 Jun;
26(8):3478-3481.
PMID: 38840474
No abstract available.
17.
Rawshani A, Eliasson B, Boren J, Sattar N, Bhatt D, El-Khalili L, et al.
Lancet Reg Health Eur
. 2024 May;
39:100888.
PMID: 38803635
Background: Few studies have explored long-term trends and risk factors for peripheral arterial complications in type 2 diabetes compared to the general population. Our research focuses on identifying optimal risk...
18.
Avdic T, Eliasson B, Rawshani A, Boren J, Gerstein H, Nordanstig J, et al.
Lancet Reg Health Eur
. 2024 May;
39:100852.
PMID: 38803631
Background: Observational studies on long-term trends, risk factor association and importance are scarce for type 1 diabetes mellitus and peripheral arterial outcomes. We set out to investigate trends in non-coronary...
19.
Sattar N, Lee M, McGuire D
Nat Med
. 2024 May;
30(7):1830-1831.
PMID: 38796654
No abstract available.
20.
Sattar N, Neeland I, McGuire D
Circulation
. 2024 May;
149(21):1621-1623.
PMID: 38768272
No abstract available.